Two-Pronged attack tested for Tough-to-Treat colon cancer
NCT ID NCT04166383
Summary
This study tested a combination of two drugs, VB-111 and nivolumab, for people with advanced colorectal cancer that had spread to the liver and had stopped responding to standard chemotherapy. The main goals were to check if the treatment was safe and to see if it could cause tumors to shrink. The trial was small and has been terminated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.